Use of epidemiological analyses in Clinical Practice Guideline
development focused on the diabetic patients treated with
insulin

J 2019

Use of epidemiological analyses in Clinical Practice Guideline development focused on the diabetic patients treated with insulin

KLUGAR, Miloslav, Jitka KLUGAROVÁ, Andrea POKORNÁ, Klára BENEŠOVÁ, Jiří JARKOVSKÝ et. al.

Basic information

Original name

Use of epidemiological analyses in Clinical Practice Guideline development focused on the diabetic patients treated with insulin

Authors

KLUGAR, Miloslav (203 Czech Republic, belonging to the institution), Jitka KLUGAROVÁ (203 Czech Republic, belonging to the institution), Andrea POKORNÁ (203 Czech Republic, guarantor, belonging to the institution), Klára BENEŠOVÁ (203 Czech Republic, belonging to the institution), Jiří JARKOVSKÝ (203 Czech Republic, belonging to the institution), Dana DOLANOVÁ (703 Slovakia, belonging to the institution), Jan MUŽÍK (203 Czech Republic, belonging to the institution), Radim LÍČENÍK (203 Czech Republic, belonging to the institution), Martin PRÁZNÝ (203 Czech Republic), Petra BÚŘILOVÁ (203 Czech Republic, belonging to the institution), Martin HUNČOVSKÝ (203 Czech Republic), Tomáš NEČAS (203 Czech Republic), Zuzana KELNAROVÁ (203 Czech Republic, belonging to the institution) and Ladislav DUŠEK (203 Czech Republic, belonging to the institution)

Edition

International Journal of Evidence-Based Healthcare, Wolters Kluwer/Lippincott Williams & Wilkins, 2019, 1744-1609

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30230 Other clinical medicine subjects

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

URL

Impact factor

Impact factor: 1.930

RIV identification code

RIV/00216224:14110/19:00110134

Organization unit

Faculty of Medicine

DOI

http://dx.doi.org/10.1097/XEB.0000000000000188

UT WoS

000511111600016

Keywords in English

clinical practice guidelines; continuous subcutaneous insulin infusion; epidemiology; type 1 diabetes mellitus

Abstract

V originále

The prevalence of diabetes is on the rise worldwide especially in developed countries. The aim of glucose management in all types of diabetes is to minimize chronic and acute complications associated with diabetes. All patients with type 1 diabetes mellitus (T1DM) require insulin. Main areas of technology advances in diabetes are continuous subcutaneous insulin infusion (CSII) and also continuous glucose monitoring systems for the management of patients with both types of diabetes. It is very important to analyse the epidemiological situation within each country before and during the clinical practice guidelines (CPGs) development and implementation. The analyses will allow us to monitor the effect of the CPG after its implementation. The aim of this short communication is to analyse the epidemiology of prevalence and incidence of diabetes mellitus and use of CSII to inform development of CPGs in the Czech Republic. The analysis is developed based on the data managed by Institute of Health Information and Statistics of the Czech Republic. We used the National Register of Reimbursed Health Services 2015–2017 as primary source, and the annual report type A (Ministry of Health) 1-01: for Diabetology (A MH 004) 2007–2017 was used as validation source. The presented data are related to the year 2016 because we were able to validate them based on the data from 2015 to 2017 for this cohort of patients. The number of patients with T1DM is increasing in the Czech Republic with no significant sex difference. Life expectancy is about 11 years lower in the T1DM population. The majority of the patients are in older age; however, these are not treated with CSII compared with the younger population. From 61 533 patients with T1DM, 81% were reported with acute and chronic complications in 2016. Only 5011 of these patients were reported as using CSII.

Citovat

KLUGAR, Miloslav, Jitka KLUGAROVÁ, Andrea POKORNÁ, Klára BENEŠOVÁ, Jiří JARKOVSKÝ, Dana DOLANOVÁ, Jan MUŽÍK, Radim LÍČENÍK, Martin PRÁZNÝ, Petra BÚŘILOVÁ, Martin HUNČOVSKÝ, Tomáš NEČAS, Zuzana KELNAROVÁ and Ladislav DUŠEK. Use of epidemiological analyses in Clinical Practice Guideline development focused on the diabetic patients treated with insulin. International Journal of Evidence-Based Healthcare. Wolters Kluwer/Lippincott Williams & Wilkins, 2019, vol. 17, Supplement 1, p. „S48“-„S52“, 5 pp. ISSN 1744-1609. Available from: https://dx.doi.org/10.1097/XEB.0000000000000188.

@article{1545149,
   author = {Klugar, Miloslav and Klugarová, Jitka and Pokorná, Andrea and Benešová, Klára and Jarkovský, Jiří and Dolanová, Dana and Mužík, Jan and Líčeník, Radim and Prázný, Martin and Búřilová, Petra and Hunčovský, Martin and Nečas, Tomáš and Kelnarová, Zuzana and Dušek, Ladislav},
   article_number = {Supplement 1},
   doi = {http://dx.doi.org/10.1097/XEB.0000000000000188},
   keywords = {clinical practice guidelines; continuous subcutaneous insulin infusion; epidemiology; type 1 diabetes mellitus},
   language = {eng},
   issn = {1744-1609},
   journal = {International Journal of Evidence-Based Healthcare},
   title = {Use of epidemiological analyses in Clinical Practice Guideline development focused on the diabetic patients treated with insulin},
   url = {http://dx.doi.org/10.1097/XEB.0000000000000188},
   volume = {17},
   year = {2019}
}

TY  - JOUR
ID  - 1545149
AU  - Klugar, Miloslav - Klugarová, Jitka - Pokorná, Andrea - Benešová, Klára - Jarkovský, Jiří - Dolanová, Dana - Mužík, Jan - Líčeník, Radim - Prázný, Martin - Búřilová, Petra - Hunčovský, Martin - Nečas, Tomáš - Kelnarová, Zuzana - Dušek, Ladislav
PY  - 2019
TI  - Use of epidemiological analyses in Clinical Practice Guideline development focused on the diabetic patients treated with insulin
JF  - International Journal of Evidence-Based Healthcare
VL  - 17
IS  - Supplement 1
SP  - „S48“-„S52“
EP  - „S48“-„S52“
PB  - Wolters Kluwer/Lippincott Williams & Wilkins
SN  - 17441609
KW  - clinical practice guidelines
KW  - continuous subcutaneous insulin infusion
KW  - epidemiology
KW  - type 1 diabetes mellitus
UR  - http://dx.doi.org/10.1097/XEB.0000000000000188
L2  - http://dx.doi.org/10.1097/XEB.0000000000000188
N2  - The prevalence of diabetes is on the rise worldwide especially in developed countries. The aim of glucose management in all types of diabetes is to minimize chronic and acute complications associated with diabetes. All patients with type 1 diabetes mellitus (T1DM) require insulin. Main areas of technology advances in diabetes are continuous subcutaneous insulin infusion (CSII) and also continuous glucose monitoring systems for the management of patients with both types of diabetes. It is very important to analyse the epidemiological situation within each country before and during the clinical practice guidelines (CPGs) development and implementation. The analyses will allow us to monitor the effect of the CPG after its implementation. The aim of this short communication is to analyse the epidemiology of prevalence and incidence of diabetes mellitus and use of CSII to inform development of CPGs in the Czech Republic. The analysis is developed based on the data managed by Institute of Health Information and Statistics of the Czech Republic. We used the National Register of Reimbursed Health Services 2015–2017 as primary source, and the annual report type A (Ministry of Health) 1-01: for Diabetology (A MH 004) 2007–2017 was used as validation source. The presented data are related to the year 2016 because we were able to validate them based on the data from 2015 to 2017 for this cohort of patients. The number of patients with T1DM is increasing in the Czech Republic with no significant sex difference. Life expectancy is about 11 years lower in the T1DM population. The majority of the patients are in older age; however, these are not treated with CSII compared with the younger population. From 61 533 patients with T1DM, 81% were reported with acute and chronic complications in 2016. Only 5011 of these patients were reported as using CSII.
ER  -

KLUGAR, Miloslav, Jitka KLUGAROVÁ, Andrea POKORNÁ, Klára BENEŠOVÁ, Jiří JARKOVSKÝ, Dana DOLANOVÁ, Jan MUŽÍK, Radim LÍČENÍK, Martin PRÁZNÝ, Petra BÚŘILOVÁ, Martin HUNČOVSKÝ, Tomáš NEČAS, Zuzana KELNAROVÁ and Ladislav DUŠEK. Use of epidemiological analyses in Clinical Practice Guideline development focused on the diabetic patients treated with insulin. \textit{International Journal of Evidence-Based Healthcare}. Wolters Kluwer/Lippincott Williams \&{} Wilkins, 2019, vol.~17, Supplement 1, p.~„S48“-„S52“, 5 pp. ISSN~1744-1609. Available from: https://dx.doi.org/10.1097/XEB.0000000000000188.

Detailed Information on Publication Record